Functional Trajectory | Cancer, No. (%) | Neurodegenerative, No. (%) | Cardiac, No. (%) | Vascular, No. (%) | Respiratory, No. (%) | Other Organ Failure, No. (%) | Frailty/Debility, No. (%) | Total, No. (%) |
---|---|---|---|---|---|---|---|---|
Late decline | 9 (25.7) | 1 (2.2) | 0 (0.0) | 1 (7.14) | 2 (18.2) | 0 (0.0) | 0 (0.0) | 23 (10.8) |
Accelerated | 2 (16.2) | 0 (0.0) | 4 (11.8) | 4 (28.6) | 0 (0.0) | 1 (6.7) | 2 (10.0) | 23 (10.8) |
Moderate | 2 (29.7) | 5 (11.1) | 7 (20.6) | 3 (21.4) | 0 (0.0) | 5 (33.3) | 3 (15.0) | 45 (21.1) |
Progressively severe | 5 (20.3) | 6 (13.3) | 16 (47.1) | 3 (21.4) | 6 (54.6) | 3 (20.0) | 4 (20.0) | 53 (24.9) |
Persistently severe | 6 (8.1) | 33 (73.3) | 7 (20.6) | 3 (21.4) | 3 (27.3) | 6 (40.0) | 11 (55.0) | 69 (32.4) |
Note: Percentages may not add up to 100 because of rounding.